Strong Success of the Tender Offer Initiated by Alphatec Holdings for Common Shares and OCEANEs of EOS IMAGING
12 Mai 2021 - 7:06AM
Alphatec Holdings, Inc. (Nasdaq: ATEC) and EOS IMAGING, S.A. are
pleased to report strong progress in the tender offer filed by ATEC
for the common shares and outstanding convertible bonds (OCEANEs)
of EOS imaging, the results of which were published on May 10,
2021, by the Autorité des Marchés Financiers (AMF), with settlement
expected to occur on May 13, 2021.
Results of the offer
15,815,971 shares and 2,312,074 "OCEANEs" of EOS
IMAGING were tendered to the offer.
In accordance with the terms of the AMF's
general regulations, ATEC acquired on the market, between March 8
and May 7, 2021, 7,940,090 common shares and 174,061 OCEANEs of EOS
IMAGING.
In total, ATEC will hold 23,756,061 EOS IMAGING
common shares at the end of the settlement/ delivery transactions
scheduled on May 13, 2021, representing the same number of voting
rights, i.e. 89.1% of the common shares and voting rights of the
EOS1.
In addition, ATEC will hold 2,486,135 EOS
IMAGING OCEANEs representing 57.2% of the OCEANEs issued and
outstanding.
Reopening of the Offer
The notice of result published on May 10 by the
AMF is available on the AMF website (www.amf-france.org). In
accordance with the requirements of article 232-4 of the AMF's
general regulations, the AMF will re-open the Offer on May 17,
2021, at the same price, i.e. (i) €2.45 per share and €7.01 per
OCEANE (coupon attached and due on May 31, 2021) or (ii) €6.81 per
OCEANE (coupon detached and due on May 31, 2021), in order to allow
holders of EOS imaging who have not tendered their shares or
OCEANEs to do so.
ABOUT EOS imaging
EOS imaging is a global medical device company
that designs, develops and markets innovative, low dose 2D/3D full
body and weight-bearing imaging, rapid 3D modeling of EOS patient
X-ray images, web-based patient-specific surgical planning, and
integration of surgical plan into the operating room that
collectively bridge the entire spectrum of care from imaging to
post-operative assessment capabilities for orthopedic surgery. With
a primary focus on hips, knees, and spine, EOS imaging is targeting
a $2 billion annual market opportunity. EOS imaging has over 400
system installations in more than 40 countries generating more than
1 million patient exams annually. EOS imaging has corporate
locations in U.S., France, Canada, Germany, and Singapore, and has
more than 160 employees. For additional information, please visit
www.eos-imaging.com.
EOS imaging is listed on Compartment C of
Euronext Paris ISIN: FR0011191766 - Ticker: EOSI
ABOUT ALPHATEC HOLDINGS, INC.
Alphatec Holdings, Inc. (ATEC), through its
wholly-owned subsidiaries, Alphatec Spine,
Inc. and SafeOp Surgical, Inc., is a medical device
company dedicated to revolutionizing the approach to spine surgery
through clinical distinction. ATEC’s Organic Innovation Machine is
focused on developing new approaches that integrate seamlessly with
the SafeOp Neural InformatiX System to safely and reproducibly
treat spine’s various pathologies and achieve the goals of spine
surgery. ATEC’s vision is to become the Standard Bearer in Spine.
For more information, visit us at www.atecspine.com.
Alphatec Holdings, Inc. is listed on NasdaqISIN
: US02081G2012 - Mnémo : ATEC
ATEC Company Contact: J. Todd
Koning Chief Financial Officer
investorrelations@atecspine.com
ATEC Investor/Media Contact:
Tina Jacobsen, CFAInvestor Relations + 1 (760) 494-6790
investorrelations@atecspine.com
EOS imaging Contact:Valérie
WorrallChief Financial Officerinvestors@eos-imaging.com(+33) 1 55
25 60 60
NewCap:EOS Investors RelationsThomas Grojean
eos-imaging@newcap.eu (+33) 1 44 71 94 94
FP2COMEOS Press
RelationsFlorence Portejoiefportejoie@fp2com.fr (+33) 6 07 76 82
83
_________________________________
1 On the basis of a capital composed of
26,659,946 shares representing the same number of voting rights,
pursuant to the second paragraph of Article 223-11 of the AMF
general regulations.